The protean face of sarcoidosis revisited

disease. Kidney Int 2005; 68 [Suppl 99]: S71–S75 21. Galli F, Varga Z, Balla J et al. Vitamin E, lipid profile, and peroxidation in hemodialysis patients. Kidney Int 2001; 59 [Suppl 78]: S148–S154 22. Sardenberg C, Suassuna P, Watanabe R et al. Balance between cytokine production by peripheral blood mononuclear cells and reactive oxygen species production by monocytes in patients with chronic kidney disease. Ren Fail 2004; 26: 673–681 23. Fortuño A, San José G, Moreno MU et al. Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome. Diabetes 2006; 55: 209–215 24. Witko-Sarsat V, Gausson V, Nguyen A-T et al. AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients. Kidney Int 2003; 64: 82–91 25. Witko-Sarsat V, Friedlander M, Nguyen-Khoa T et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998; 161: 2524–2532 26. Zalba G, Beloqui O, San José G et al. NADPH oxidasedependent superoxide production is associated with carotid intima-media thickness in subjects free of clinical atherosclerotic disease. Arterioscler Thromb Vasc Biol 2005; 25: 1452–1457 27. Mancini GBJ, Dahlöf B, Dı́ez J. Surrogate markers for cardiovascular diseases: Structural markers. Circulation 2004; 109 [Suppl IV]: IV-22–IV-30 28. Yilmaz MI, Saglam M, Caglar K et al. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine. Am J Kidney Dis 2006; 47: 42–50 29. Zoccali C, Bode-Boger S, Mallamaci F et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease. Lancet 2001; 358: 2113–2117 30. Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 2000; 20: 2031–2037 31. Violi F, Cangemi R. Antioxidants and cardiovascular disease. Curr Opin Investig Drugs 2005; 6: 890–895 32. Guzik TJ, Harrison DG. Vascular NADPH oxidases as drug targets for novel antioxidant strategies. Drug Discov Today 2006; 11: 524–533